These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11714270)

  • 21. Influence of ionic strength and beta2-glycoprotein I concentration on agglutination of like-charged phospholipid membranes.
    Perutková Š; Frank-Bertoncelj M; Rozman B; Kralj-Iglič V; Iglič A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():699-706. PubMed ID: 23911627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.
    de Laat B; van Berkel M; Urbanus RT; Siregar B; de Groot PG; Gebbink MF; Maas C
    Arthritis Rheum; 2011 Dec; 63(12):3960-8. PubMed ID: 21898342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.
    Gamsjaeger R; Johs A; Gries A; Gruber HJ; Romanin C; Prassl R; Hinterdorfer P
    Biochem J; 2005 Aug; 389(Pt 3):665-73. PubMed ID: 15813706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial creatine kinase binding to phospholipids decreases fluidity of membranes and promotes new lipid-induced beta structures as monitored by red edge excitation shift, laurdan fluorescence, and FTIR.
    Granjon T; Vacheron MJ; Vial C; Buchet R
    Biochemistry; 2001 May; 40(20):6016-26. PubMed ID: 11352737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
    Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
    Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
    Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
    Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms beta2-glycoprotein I: phospholipid binding and multimeric structure.
    Gushiken FC; Le A; Arnett FC; Thiagarajan P
    Thromb Res; 2002 Nov; 108(2-3):175-80. PubMed ID: 12590955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
    Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
    Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of beta 2glycoprotein I by glutardialdehyde. Conformational changes and aggregation accompany exposure of the cryptic autoepitope.
    Galazka M; Tang M; DeBari VA; Kohles JD; Lee JK; Keil LB; Petersheim M
    Appl Biochem Biotechnol; 1999 Jan; 76(1):1-13. PubMed ID: 10327586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?
    Gharavi AE; Harris EN; Sammaritano LR; Pierangeli SS; Wen J
    J Lab Clin Med; 1993 Oct; 122(4):426-31. PubMed ID: 8228557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beta-2-glycoprotein I and antiphospholipid antibodies.
    Shoenfeld Y; Meroni PL
    Clin Exp Rheumatol; 1992; 10(2):205-9. PubMed ID: 1505119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of poly-(L-lysine) and porin on the domain structure of mixed vesicles composed of lipopolysaccharide and phospholipid: an infrared spectroscopic study.
    Lasch P; Schultz CP; Naumann D
    Biophys J; 1998 Aug; 75(2):840-52. PubMed ID: 9675185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation-Mechanisms analyzed using hydrogen/deuterium exchange.
    Tang KT; Wu TY; Chen HH; Lin CC; Hsu YH
    Protein Sci; 2021 May; 30(5):927-939. PubMed ID: 33641242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid interactions with human antiphospholipid antibody, beta 2-glycoprotein 1, and normal human IgG using the fluorescent probes NBD-PE and DPH.
    Tang D; Borchman D; Harris N; Pierangeli S
    Biochim Biophys Acta; 1998 Jun; 1372(1):45-54. PubMed ID: 9651477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78.
    Hagihara Y; Enjyoji K; Omasa T; Katakura Y; Suga K; Igarashi M; Matsuura E; Kato H; Yoshimura T; Goto Y
    J Biochem; 1997 Jan; 121(1):128-37. PubMed ID: 9058203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes.
    Willems GM; Janssen MP; Comfurius P; Galli M; Zwaal RF; Bevers EM
    Biochemistry; 2000 Feb; 39(8):1982-9. PubMed ID: 10684648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of membrane phase behavior as a tool to detect extrinsic protein-induced domain formation: binding of prothrombin to phosphatidylserine/phosphatidylcholine vesicles.
    Tendian SW; Lentz BR
    Biochemistry; 1990 Jul; 29(28):6720-9. PubMed ID: 2397210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.